FDA recall, , Moderate risk
HCSC-Blood Center Plasma and Red Blood Cells
PF24 Plasma and Red Blood Cells, Leukocytes Reduced, with or without irradiation, were distributed after incomplete donor screening.
Recall ended Sep 23, 2026. Still check yours.
What happened
HCSC-Blood Center began a recall on May 29, 2025, of Red Blood Cells, Leukocytes Reduced, Irradiated; Red Blood Cells, Leukocytes Reduced; and PF24 Plasma, each one unit, because they were collected from a donor for whom donor eligibility screening was incomplete and were distributed. The FDA classified the recall on September 23, 2026, and the products were distributed in Pennsylvania.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
3 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced, Irradiated
Reason: Red Blood Cells, Leukocytes Reduced, Irradiated, collected from a donor for whom donor eligibility screening was incomplete, were distributed.
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, collected from a donor for whom donor eligibility screening was incomplete, were distributed.
PF24 Plasma
Reason: PF24 Plasma, collected from a donor for whom donor eligibility screening was incomplete, was distributed.
Recall details
- Company began the recall
- Sold in
- Company
- HCSC-Blood Center
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99047
- Recall numbers
- B-0203-2026 to B-0205-2026
All recalls from HCSC-Blood Center
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary


